First Time Loading...
V

Vifor Pharma AG
SIX:VIFN

Watchlist Manager
Vifor Pharma AG
SIX:VIFN
Watchlist
Price: 166.15 CHF 0.48% Market Closed
Updated: May 2, 2024

Vifor Pharma AG
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vifor Pharma AG
Revenue Peer Comparison

Comparables:
NOVN
NLSP
ROG
S
SDZ

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
V
Vifor Pharma AG
SIX:VIFN
Revenue
CHf1.8B
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
-7%
Novartis AG
SIX:NOVN
Revenue
$46.7B
CAGR 3-Years
-2%
CAGR 5-Years
0%
CAGR 10-Years
-1%
NLS Pharmaceutics AG
NASDAQ:NLSP
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Roche Holding AG
SIX:ROG
Revenue
CHf58.7B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
2%
S
Sandoz Group AG
SIX:SDZ
Revenue
$9.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Vifor Pharma AG's Revenue?
Revenue
1.8B CHF

Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Revenue amounts to 1.8B CHF.

What is Vifor Pharma AG's Revenue growth rate?
Revenue CAGR 10Y
-7%

Over the last year, the Revenue growth was 3%. The average annual Revenue growth rates for Vifor Pharma AG have been 3% over the past three years , 8% over the past five years , and -7% over the past ten years .